HC Wainwright Brokers Boost Earnings Estimates for ADAP
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Free Report) – Research analysts at HC Wainwright raised their Q2 2025 earnings per share estimates for Adaptimmune Therapeutics in a note issued to investors on Wednesday, May 14th. HC Wainwright analyst A. He now forecasts that the biotechnology company will post earnings per share of ($0.03) for the quarter, […]
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Free Report) – Research analysts at HC Wainwright raised their Q2 2025 earnings per share estimates for Adaptimmune Therapeutics in a note issued to investors on Wednesday, May 14th. HC Wainwright analyst A. He now forecasts that the biotechnology company will post earnings per share of ($0.03) for the quarter, […]
